KAREN GAFFORD: Open Payments
NPI 1659552511 · GOODYEAR, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$329 in 17 payments from 5 companies in 2025. Trend: 2023 $50 · 2024 $502 · 2025 $329
Food & beverage: $329
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 9 | $192 |
| Regeneron Healthcare Solutions, Inc. | 3 | $52 |
| Lilly USA, LLC | 2 | $37 |
| ABBVIE INC. | 2 | $31 |
| Galderma Laboratories, L.P. | 1 | $16 |
Products named: COSENTYX, DUPIXENT, TALTZ, SKYRIZI, NEMLUVIO, Rhapsido.
Industry payments across AZ — which companies pay providers there.
